Category: Disease Discoveries
-
Genetic Links to Asthma in People of African Ancestry
A team of scientists has identified new genetic regions associated with asthma in people of African ancestry, according to a study published in Nature Communications.
-
Study Explores How Pneumonia Strains Compete
A recent study has shed light on how different strains of bacteria compete to cause pneumonia, findings that could inform how to best prevent infection.
-
Brain Stimulation Reverses Age-Related Memory Loss
Stimulating one part of the brain’s memory center with electromagnetic pulses improved the memory of older adults with age-related memory loss, according to a recent study.
-
Newly Discovered Protein Explains Leukemia’s Treatment Resistance
Northwestern scientists recently identified a new protein complex that is upregulated in acute myeloid leukemia, potentially explaining why current therapies are often ineffective.
-
Eyes May Reveal Early Alzheimer’s Disease
Reduced blood capillaries in the back of the eye may be a new, noninvasive way to diagnose early cognitive impairment, a precursor to Alzheimer’s disease.
-
Circadian Clock Plays Unexpected Role in Neurodegenerative Diseases
Interruptions in circadian rhythm protected against damage in a model of Huntington’s disease, suggesting an unexpected neuroprotective effect for mild stress to the brain from irregular patterns of sleep.
-
Scientists Identify Therapeutic Target in Diabetic Kidney Disease
In a study published in the Journal of Experimental Medicine, Northwestern Medicine scientists identified a new therapeutic target that may help protect kidney function in patients with diabetes.
-
Tumor Mutations Predict Response to Immunotherapy
A recent Northwestern Medicine study found that patients with glioblastoma responded better or worse to immunotherapy depending on the presence of certain mutations in their tumors.
-
Alzheimer’s Treatment Holds Promise for Primary Progressive Aphasia Patients
Northwestern Medicine scientists have discovered that an existing therapy used to treat Alzheimer’s disease might also work on patients with Primary Progressive Aphasia, a type of dementia that destroys language and currently has no treatment.
-
Nanoparticle Peptides Could Fight Neurodegenerative Disease
According to a recent study, a novel nanoparticle-based drug repaired neurons and improved microvasculature in a mouse model of spinocerebellar ataxia 1, a degenerative disease that affects the cerebellum.
